Over the past 25 years, Quantel Medical has been involved in developing and providing state-of-the-art technologies for the diagnosis and treatment of the four major causes of blindness: cataract, glaucoma, age-related macular degeneration (AMD) and diabetic retinopathy (DR).

IPL System

* Not FDA Approved

  • Dry eye treatment: Meibomian Glands Dysfunction (MGD) and inflammation (rosacea & blepharitis)
  • Safe, effective and long-lasting treatment
  • Simple and fast treatment (<5 min)
  • Treatment on a wide range of skin types thanks to the optimized technical characteristics (train of pulses, filter at 610nm, cooling system).


  • Improved tear film quality and symptoms
  • Optimize post-surgical results by diagnosing and treating before surgery (refractive, cataract)
  • Improve the compliance of patients under topical treatment
  • Improve the comfort of contact lens wearer

Not Available


    • Analysis of Cytokine Levels in Tears and Clinical Correlations After Intense Pulsed Light Treating Meibomian Gland Dysfunction

    • Neurotransmitter Influence on Human Meibomian Gland Epithelial Cells

    • Update on the management of rosacea

    • Vasoactive Intestinal Polypeptide and the Innervation of the Human Lacrimal Gland

    • Rosacea: Epidemiology, pathogenesis, and treatment

    • Parasympathetic Innervation of the Meibomian Glands in Rats

    • The Ocular Surface


Lacrystim - Treatment of dry eye


Interview of Dr. Trone: Dry Eye Treatment with Lacrystim


SFO 2019 - Light on a new dry eye therapy


Patient Protection Shells

Practitioner Protective Goggles

Mailing Image
Facebook YouTube LinkedIn Contact Us